1. Won their Injunction 2. PreClinical Trials for its Immunotronics Platform 3. Filed for Orphan Drug Status 4. Over 20 patents 5. Form 4s filed by insiders 6. Converts being bought by Company and Institutions 7. Uplistment 8. President and CEO has been filing form 4's everyday so far the past couple weeks
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.